Mizuho Raises DexCom (DXCM) Price Target to $90 from $78 After Earnings Beat
We recently published an article titled 13 Best Internet of Things (IoT) Stocks to Buy Now.
On February 13, Mizuho analyst Anthony Petrone raised the price target on DexCom, Inc. (NASDAQ:DXCM) to $90 from $78 while maintaining an Outperform rating, citing a favorable post-earnings setup following a quarterly beat that exceeded expectations.
The previous day, DexCom, Inc. (NASDAQ:DXCM) reported fourth-quarter revenue of $1.26 billion, slightly above the $1.25 billion consensus estimate. Management highlighted 2025 as a year of expanded access to continuous glucose monitoring (CGM) solutions and the launch of the Dexcom G7 15 Day System. For 2026, the company guided revenue to a range of $5.16 billion to $5.25 billion, representing projected growth of 11%–13%. Non-GAAP gross margin is expected between 63% and 64%, with an operating margin of approximately 22%–23% and an adjusted EBITDA margin of 30%–31%. Gross margin expansion of 200–300 basis points is anticipated in 2026, driven by lower freight costs, manufacturing efficiencies, and a favorable product mix associated with the G7 15-day platform. The combination of sustained double-digit revenue growth, expanding margins, and operational leverage underscores improving profitability and cash generation, strengthening the investment thesis around durable category leadership in CGM technology.
DexCom, Inc. (NASDAQ:DXCM), headquartered in San Diego, California, is a medical device company specializing in the development, manufacturing, and distribution of continuous glucose monitoring systems for diabetes management. Founded in 1999, the company operates at the intersection of healthcare and connected device ecosystems, positioning it as a central participant in the Internet of Medical Things.
While we acknowledge the potential of DXCM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 8 Up and Coming Streaming Companies and Services and 9 High Growth Canadian Stocks to Buy
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wall Street Sees Nifty at 30,000: Why Are Foreign Investors Still Selling Indian Stocks?
UBS: Maintains Tesla (TSLA.US) “Neutral” rating, target price $385, AI narrative dominates stock price pricing logic
UBS predicts that Tesla's global deliveries in the third quarter of 2026 (3Q26) will be approximately 470,000 vehicles, representing a year-on-year decrease of 5% and a quarter-on-quarter decrease of 1%.
Altcoin Price Targets Point to Six 2027 Levels
The AI frenzy withstands the "5% US Treasury yield"! Nasdaq hits new highs, strengthening the "80/20" pattern as Wall Street reassesses stock-bond allocation
The 30-year US Treasury yield briefly reached about 5.53%, hitting its highest level since 2004, while Brent crude remains above $100 per barrel. Risk assets have once again withstood the pressure, reflecting investors' continued belief that the commercialization of AI applications and corporate profit growth can to some extent offset the impact of rising financing costs and discount rates.
Crypto prices
More
